Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Effective wealth accumulation strategies are key to financial success. Learn how to grow your assets and secure your future.
11,541 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
The Dow rose above a key threshold—49,683.30—on Thursday, putting it on a path to officially exit correction territor...
LoanDepot posted a larger first-quarter loss as market volatility and thinner gain-on-sale margins weighed on revenue...
As ELAN reports Q1 2026 earnings, investors want clarity on growth, margins, and guidance. This analysis breaks down ...
Is Occidental Petroleum a solid buy, a risky hold, or a limited-scope sell? This guide breaks down the business, the ...
A former antitrust prosecutor who helped litigate the JetBlue-Spirit merger shares lessons for future airline regulat...
XSHD's high-yield strategy faces a payout squeeze as distributions shrink while prices slide. The result: a 5%–7% yie...
A sweeping study finds AI financial tools may simulate emotional states, including addiction-like responses and dread...
A SpaceX IPO could reshape growth investing, creating upside for Rivian and other high-growth names. This guide break...
A major institutional move signals a shift in risk tolerance and strategy. Learn what arcus capital scales back means...
As Absci releases its 2026 earnings outlook, investors gain a clearer view of runway, milestones, and collaboration p...
In a crowded AI market, a stock nobody watching that quietly compounds growth could deliver outsized returns. This gu...